2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell LymphomaRelapsed and/or Refractory B-cell LymphomaRecruitingPhase 1 / Phase 22026-09-25NCT04989803
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite StudiesHemic and Lymphatic Diseases, Neoplasms by Site, autoimmune disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, neoplasmEnrolling by invitationNot stated2026-09-21NCT05041309